Segmentation in Healthcare Cybersecurity Boils Down to Securing the Network and Protecting Patients

Device42

 

As healthcare institutions increasingly digitize their operations, the vulnerability of their networks to cyber breaches has highlighted the urgent need for robust cybersecurity measures. A recent Experts Talk discussion on cybersecurity risks in healthcare explores the pivotal role of network segmentation in fortifying these efforts. With patient data and healthcare service continuity at stake, the discussion underscores why overlooking healthcare cybersecurity is not an option.

Is network segmentation the key to defending our healthcare systems against cyber threats, or could it complicate patient care delivery?

Dr. Robin Berthier, CEO and Co-Founder of Network Perception, and Michael Isbitski, Director of Cybersecurity and Strategy at Sysdig, discuss the strategic implementation of network segmentation as part of a broader healthcare cybersecurity framework. Their insights are crucial for understanding how to shield healthcare networks effectively while maintaining operational efficiency.

Key takeaways from their discussion include:

  • Essential Cybersecurity Strategy: Segmentation is fundamental to healthcare cybersecurity, similar to compartmentalizing sections of a ship to prevent it from sinking
  • Security vs. Accessibility: Effective segmentation must secure networks without disrupting healthcare service delivery
  • Comprehensive Access Controls: Implementing stringent access controls is vital for mitigating risks in the digital supply chain
  • Complex Implementation Challenges: Proper segmentation requires careful planning to integrate strong security measures without impacting critical healthcare functions
  • Patient Care Priority: Cybersecurity measures, including segmentation, must always consider their potential impact on patient care, ensuring that enhancements do not hinder service quality

Berthier and Isbitski illuminate the delicate balance required to integrate advanced cybersecurity tactics like segmentation within the healthcare sector, emphasizing the dual goals of safeguarding patient information and ensuring uninterrupted healthcare services.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More